{"id":227592,"date":"2026-09-02T12:58:29","date_gmt":"2026-09-02T07:28:29","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=227592"},"modified":"2026-09-02T12:58:30","modified_gmt":"2026-09-02T07:28:30","slug":"is-bajaj-healthcare-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-bajaj-healthcare-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Bajaj Healthcare a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"

Bajaj Healthcare share price around Rs 329. 36.2% below 52-week high of Rs 516. Q1 FY27 revenue Rs 166 crore, up 11.3% YoY. PAT Rs 14 crore, up 15.8%. PE 63x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Bajaj Healthcare’s Q1 FY27 results were strong, with revenue at Rs 166 crore and PAT climbing 16% to Rs 14 crore. The stock trades at a PE of 63x against an industry average near 51x, so some of this good news is already priced in. The Bajaj Healthcare share price near Rs 329 reflects that optimism, so investors weighing whether Bajaj Healthcare is a good buy today should focus on whether this pace of growth can be sustained rather than just this quarter’s print.<\/p>\n<\/div>\n

The Bajaj Healthcare share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Bajaj Healthcare is a pharmaceutical company manufacturing active pharmaceutical ingredients and formulations, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 166 crore, up 11.3% year on year, while profit after tax came in at Rs 14 crore, up 15.8% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Bajaj Healthcare share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Bajaj Healthcare share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n